GTR 118843812
Tenders Are Invited For Immune Sera And Immunoglobulins - Normal Human Immunoglobulin 10%
ICB — International Competitive Bid
Closes Oct 30, 2026
Europe
Tender Information
GTR Reference
118843812
Tendering Authority
Subscribe to view
Tender No
673851-2026
Financer Name
Self-Funded
Work Title
Tenders Are Invited For Immune Sera And Immunoglobulins - Normal Human Immunoglobulin 10%
Bid Type
ICB — International Competitive Bid
Country
Subscribe to view
Geographical Region
Europe
Political Region
European Union
Last Date of Bid Submission
30-10-2026
Work Detail
Immune Sera And Immunoglobulins - Normal Human Immunoglobulin 10%. This Medicine Belongs To A Group Of Medicines Called Intravenous Immunoglobulins. These Drugs Are Used To Treat Patients In Situations Where Their Defense (Immune) System Is Not Working Well Enough. The Drug Is Used To Treat: For Patients Who Do Not Have Enough Antibodies (Substitution Therapy) And Patients With A Certain Autoimmune Disease (Immunomodulation).
Key Value
Tender Value
1,285,772 - SKK
Tender Documents
Global Tender Document
64756035-ab83-4b11-94df-4032a5ed7ed2.html
Attachments
Additional Details Available on Click
- Tendering Authority
- Publication Document (Tender Document / Tender Notice)
Disclaimer
We take all possible care for accurate & authentic tender information. However, users are requested to refer to the original Tender Notice / Tender Document published by the Tender Issuing Agency before taking any decision regarding this tender.